% | $
Quotes you view appear here for quick access.

Bio-Rad Laboratories, Inc. Message Board

  • cyrusabdinh cyrusabdinh Aug 29, 2012 11:22 PM Flag


    HERCULES, CA--(Marketwire -08/29/12)- Bio-Rad Laboratories, Inc. (BIO) and (BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of a Digital Biology Center to focus on the development of innovative new products based on the company's recently acquired droplet partitioning technology. The first product based on this technology, Bio-Rad's QX100™ Droplet Digital™ PCR system that was introduced last year, applies a sample partitioning technology to polymerase chain reaction (PCR) and offers a new approach to nucleic acid quantification.
    PCR is widely used to amplify and quantify nucleic acids. Droplet digital PCR offers researchers a new level of precision in the quantification of target nucleic acid molecules, providing accurate determination of copy number variation as well as the detection of rare mutation events such as those seen in certain tumors. Applications of these capabilities have the potential to provide new strategies for diagnosis of inherited disorders, cancer, and infectious disease.
    "We believe the digital droplet partitioning technology, which is at the heart of our recently launched QX100 Droplet Digital PCR instrument, has potential far beyond the digital PCR market," said Annette Tumolo, Director, Digital Biology Center. "Our mission is to provide innovative products that deliver powerful, accessible solutions for digital biology and expand the reach of our digital droplet PCR technology."

134.94-2.47(-1.80%)Apr 27 4:00 PMEDT